Search Results 41-50 of 16701 for CLL

1. Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers - Mayo Clinic News Network

   ... chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.

2. Overview - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

   The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic studies the genetic epidemiology of chronic lymphocytic leukemia (CLL), monoclonal B-cell ...

3. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

   ... Chronic Lymphocytic Leukemia (CLL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

4. Acalabrutinib (oral route) - Mayo Clinic

   This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This medicine is available only with your ...

5. Analysis of Immunostaining during Mohs Micrographic Surgery to Improve Detection of Negative Surgical Margins in Patients with Squamous Cell Carcinoma and Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL) - Mayo Clinic

   ... Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL). Print ... chronic lymphocytic leukemia (CLL)/non-Hodgkin lymphoma (NHL). The study will ...

6. Leukemia Clinical Trials

   ... chronic lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL ...

7. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

   ... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

8. Ibrutinib (oral route) - Mayo Clinic

   Description. Ibrutinib is used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL)/small ...

9. Acute lymphocytic leukemia - Symptoms and causes - Mayo Clinic

   Anyone have chronic lymphocytic leukemia (CLL)?. 46 Replies Thu, May 01, 2025. cdurbin · What are most common side effects when starting HU (Hydroxyurea)?. 164 ...

10. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...